|
DSCC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.194100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.704000E-01 |
| Normal-vs-Stage2 |
4.093900E-02 |
| Normal-vs-Stage3 |
4.171900E-02 |
| Normal-vs-Stage4 |
2.916400E-02 |
| Stage1-vs-Stage2 |
1.626950E-01 |
| Stage1-vs-Stage3 |
2.361600E-01 |
| Stage1-vs-Stage4 |
9.180300E-02 |
| Stage2-vs-Stage3 |
6.655000E-01 |
| Stage2-vs-Stage4 |
8.379200E-01 |
| Stage3-vs-Stage4 |
5.065200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.521800E-02 |
| Normal-vs-AfricanAmerican |
7.883300E-03 |
| Normal-vs-Asian |
1.881640E-01 |
| Caucasian-vs-AfricanAmerican |
2.260200E-02 |
| Caucasian-vs-Asian |
8.885600E-01 |
| AfricanAmerican-vs-Asian |
5.438100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.867670E-02 |
| Normal-vs-Female |
6.921700E-02 |
| Male-vs-Female |
1.316370E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.986400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.138000E-03 |
| Normal-vs-Age(61-80Yrs) |
7.625500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.150400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.421500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.359800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.879200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.446800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.212800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.178600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.642400E-01 |
| Classical-VS-Follicular |
5.847200E-01 |
| Classical-VS-Other |
2.632200E-01 |
| Classical-VS-Normal |
1.002770E-01 |
| Tall-VS-Follicular |
3.387400E-01 |
| Tall-VS-Other |
1.940800E-01 |
| Tall-VS-Normal |
5.305200E-01 |
| Follicular-VS-Other |
3.844600E-01 |
| Follicular-VS-Normal |
6.106400E-02 |
| Other-VS-Normal |
1.371420E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.198400E-02 |
| Normal-vs-N1 |
9.271800E-02 |
| N0-vs-N1 |
6.489000E-01 |
|
|
